Akcea Therapeutics, Inc. AKCA is scheduled to report second-quarter results on Aug 4. Akcea’s stock has lost 29% in the year so far against the industry's growth of 5%. The company beat earnings ...
Hosted on MSN
Sayit Akca admits involvement in Dural caravan of explosives but denies orchestrating antisemitic attacks
Sayit Akca, the man accused of orchestrating a series of antisemitic attacks in Sydney, has spoken exclusively to Four Corners, admitting he was involved in sourcing a caravan full of explosives.
Investors might want to bet on Akcea Therapeutics (AKCA), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results